Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7898065 | 0.80 | ACHE (0.47) | PKMMAPTERBB2MEN1KMT2A | |
| SCHEMBL9105522 | 0.71 | ERBB2 (0.34) | ERBB2 | |
| SCHEMBL9886530 | 0.71 | ERBB2 (0.34) | ERBB2 | |
| SCHEMBL9911033 | 0.71 | ERBB2 (0.34) | ERBB2 | |
| SCHEMBL22980337 | 0.64 | ERBB2 (0.35) | PKMMAPTERBB2MEN1KMT2A | |
| SCHEMBL3624689 | 0.57 | PRKCE (0.37) | MAPTDAOMEN1KMT2AL3MBTL1 | |
| SCHEMBL134443 | 0.57 | IDO1 (0.46) | — | |
| SCHEMBL3356030 | 0.57 | ALDH1A1 (0.48) | MAPTDAOMEN1KMT2AL3MBTL1 | |
| SCHEMBL31329428 | 0.57 | DAO (0.46) | PKMMAPTDAOL3MBTL1TDP1 | |
| SCHEMBL277926 | 0.56 | MGLL (0.55) | PKMMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3708673-B1 | METHOD AND DEVICE FOR ELECTRONICALLY CONTROLLING THE PH OF A SOLUTION | BOSCH GMBH ROBERT (DE) | 2025-03-26 | — | — | EP | disclosed |
| EP-3320410-B1 | ELECTRONIC CONTROL OF THE PH OF A SOLUTION CLOSE TO AN ELECTRODE SURFACES | BOSCH GMBH ROBERT (DE) | 2024-09-25 | — | — | EP | disclosed |
| EP-4172353-A1 | ELECTRONIC CONTROL OF THE PH OF A SOLUTION CLOSE TO AN ELECTRODE SURFACE | Robert Bosch GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-11561198-B2 | Electronic control of the pH of a solution close to an electrode surface | ROBERT BOSCH GMBH (DE) | 2023-01-24 | — | — | US | disclosed |
| US-11561198-B2 | Electronic control of the pH of a solution close to an electrode surface | ROBERT BOSCH GMBH (DE) | 2023-01-24 | — | — | US | disclosed |
| US-10942146-B2 | Electrochemically active agents for pH modulation in biological buffers | ROBERT BOSCH GMBH (DE) | 2021-03-09 | — | — | US | disclosed |
| US-10942146-B2 | Electrochemically active agents for pH modulation in biological buffers | ROBERT BOSCH GMBH (DE) | 2021-03-09 | — | — | US | disclosed |
| EP-3320332-B1 | METHODS FOR GENERATING PH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR BUBBLE DETECTION USING ELECTRODES | BOSCH GMBH ROBERT (DE) | 2021-03-03 | — | — | EP | disclosed |
| US-20200363371-A1 | ELECTRONIC CONTROL OF THE PH OF A SOLUTION CLOSE TO AN ELECTRODE SURFACE | ROBERT BOSCH GMBH (DE) | 2020-11-19 | — | — | US | disclosed |
| EP-3708673-A1 | METHOD AND DEVICE FOR ELECTRONICALLY CONTROLLING THE PH OF A SOLUTION | Robert Bosch GmbH (DE) | 2020-09-16 | — | — | EP | disclosed |
| US-20170010238-A1 | ELECTRONIC CONTROL OF THE pH OF A SOLUTION CLOSE TO AN ELECTRODE SURFACES | ROBERT BOSCH GMBH (DE) | 2017-01-12 | — | — | US | disclosed |
| US-20160025671-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS | ROBERT BOSCH GMBH (DE) | 2016-01-28 | — | — | US | disclosed |
| US-20160025671-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS | ROBERT BOSCH GMBH (DE) | 2016-01-28 | — | — | US | disclosed |
| US-20160025671-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS | ROBERT BOSCH GMBH (DE) | 2016-01-28 | — | — | US | disclosed |
| US-20160003763-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS, AND BUBBLE DETECTION USING ELECTRODES | ROBERT BOSCH GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-20160003763-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS, AND BUBBLE DETECTION USING ELECTRODES | ROBERT BOSCH GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-20160003763-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS, AND BUBBLE DETECTION USING ELECTRODES | ROBERT BOSCH GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-20160003766-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS | ROBERT BOSCH GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-20160003766-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS | ROBERT BOSCH GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-20160003766-A1 | METHODS FOR GENERATING pH/IONIC CONCENTRATION GRADIENT NEAR ELECTRODE SURFACES FOR MODULATING BIOMOLECULAR INTERACTIONS | ROBERT BOSCH GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10942146-B2 | Electrochemically active agents for pH modulation in biological buffers | CA2, PDE7A, CA1 | STAT3 884/4885PKM 2988/4885MAPT 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.